Cyclosporine Ophthalmic

Major

Cyclosporine Ophthalmic Artemether Increased artemether/lumefantrine exposure, an increased risk of QT prolongation, reduced CYP3A4 substrate exposure and reduced ef... Details Cyclosporine Ophthalmic Asciminib Scemblix Increased exposure to CYP3A4/P-gp substrates and increased risk of CYP3A4/P-gp substrates-related adverse effects Details Cyclosporine Ophthalmic Aspirin Acuprin® An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Asunaprevir Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Atogepant Qulipta Increased atogepant exposure Details Cyclosporine Ophthalmic Atorvastatin Atorvaliq Increased atorvastatin exposure, an increased risk of myopathy or rhabdomyolysis and an increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Atrasentan Increased atrasentan exposure and an increased risk of atrasentan-related adverse reactions Details Cyclosporine Ophthalmic Avacopan Tavneos Increased exposure to CYP3A4 substrate Details Cyclosporine Ophthalmic Azathioprine Azasan Reduced cycloSPORINE exposure and an increased risk of hepatotoxicity Details Cyclosporine Ophthalmic Azilsartan Edarbi An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Azilsartan Medoxomil Edarbi An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Azithromycin AzaSite Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Bacillus Of Calmette And Guerin Vaccine, Live An inadequate immunological response to the vaccine, increased risk of disseminated infection with live vaccines and reduced effic... Details Cyclosporine Ophthalmic Bedaquiline Sirturo Increased bedaquiline exposure Details Cyclosporine Ophthalmic Belumosudil Rezurock Increased P-gp substrate exposure Details Cyclosporine Ophthalmic Belzutifan Welireg Reduced CYP3A4 substrates with NTI exposure and reduced efficacy of CYP3A4 substrates with NTI Details Cyclosporine Ophthalmic Benazepril Lotensin Acute renal dysfunction and an increased risk of hyperkalemia Details Cyclosporine Ophthalmic Benzhydrocodone Increased HYDROcodone exposure and risk of increased or prolonged opioid effects Details Cyclosporine Ophthalmic Berotralstat Orladeyo Increased CYP3A4/P-gp substrate exposure Details Cyclosporine Ophthalmic Betrixaban Bevyxxa® Increased betrixaban exposure and increased risk of bleeding Details Cyclosporine Ophthalmic Bezafibrate Increased risk of renal dysfunction Details Cyclosporine Ophthalmic Bimekizumab-Bkzx Altered cycloSPORINE exposure Details Cyclosporine Ophthalmic Black Cohosh Reduced immunosuppressive drug effectiveness and acute transplant rejection Details Cyclosporine Ophthalmic Boceprevir Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Bosutinib Bosulif Increased bosutinib exposure Details Cyclosporine Ophthalmic Brigatinib Alunbrig Increased brigatinib exposure Details Cyclosporine Ophthalmic Bromfenac Bromsite An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Bromocriptine Cycloset Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Budesonide Entocort Increased budesonide exposure Details Cyclosporine Ophthalmic Bufexamac An increased risk of cycloSPORINE nephrotoxicity Details Cyclosporine Ophthalmic Buprenorphine Belbuca Increased buprenorphine exposure and an increased risk of buprenorphine-related adverse events Details Cyclosporine Ophthalmic Bupropion Aplenzin Increased risk of seizures Details Cyclosporine Ophthalmic Canagliflozin Invokana Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Candesartan Atacand An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Canrenoate An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Canrenone An increased risk of hyperkalemia Details Cyclosporine Ophthalmic Capivasertib Truqap Increased capivasertib exposure and an increased risk of capivasertib-related adverse reactions Details Cyclosporine Ophthalmic Capmatinib Tabrecta Increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Captopril Capoten® Acute renal dysfunction, increased risk of hyperkalemia and an increased cycloSPORINE exposure Details Cyclosporine Ophthalmic Carbamazepine Carbatrol Reduced cycloSPORINE exposure Details